Gold Rallies Rs 580 To Rs 97,030 In Delhi; Silver Climbs Rs 500

Last Updated:
'Gold prices edge higher, but remain under pressure, as softer US PPI and CPI data for April indicate disinflation,' says Abans Financial Services CEO Chintan Mehta.
Gold prices rallied Rs 580 to Rs 97,030 per 10 grams in the national capital on Monday amid strong trends in the international markets, according to the All India Sarafa Association. On Friday, the precious metal of 99.9 per cent purity had closed at Rs 96,450 per 10 grams.
Gold of 99.5 per cent purity climbed Rs 580 to Rs 96,580 per 10 grams (inclusive of all taxes) on Monday. It had settled at Rs 96,000 per 10 grams in the previous market session.
'Gold prices edge higher, but remain under pressure, as softer US PPI and CPI data for April indicate disinflation. At the same time, the US Treasury yield is approaching 4.5 per cent, extending Friday's rebound after rating agency Moody's downgraded the US credit rating from Aaa to Aa1," Abans Financial Services Chief Executive Officer Chintan Mehta said.
This move has reignited interest in gold, as investors reduce exposure to US Treasury bills and seek a safe haven asset, Mehta added.
Additionally, silver appreciated by Rs 500 to Rs 98,500 per kg (inclusive of all taxes). The white metal had ended at Rs 98,000 per kg on Friday.
Meanwhile, the most traded contract for gold futures rallied Rs 1,182 or 1.28 per cent to trade at Rs 93,623 per 10 grams on the Multi Commodity Exchange (MCX).
Silver futures for July delivery increased Rs 662 to trade at Rs 95,980 per kg on the commodities bourse.
On the global front, spot gold went up by USD 39.05 or 1.22 per cent to USD 3,241.82 per ounce.
'Focus during the week will be on the US macroeconomic data such as manufacturing/ services PMI, and housing data," Pranav Mer, Vice President, EBG – Commodity & Currency Research, JM Financial Services, said.
The data release will provide more impetus for the US Federal Reserve's future monetary policy cycle.
According to Goldman Sachs, gold will rise to $3,700 per ounce by the end of 2025, as central banks continue to buy tonnes of the precious metal every month.
The commodity is also likely to climb as ETF investors increase their holdings in anticipation of interest rate cuts by the US Federal Reserve and amid growing recession concerns.
In the event of a recession, Goldman Sachs forecasts that gold could rise to as much as $3,880 per ounce, the investment banking firm said in a note.
(This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI)

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

News18

16 minutes ago

• News18

Influx Healthtech IPO Allotment: A Step-By-Step Guide To Check Status Online Today, Know Latest GMP

Last Updated: According to market observers, the GMP of the Influx Healthtech IPO is 22.92%, indicating decent listing gains for investors. Influx Healthtech IPO Allotment: The initial public offering of Influx Healthtech has received a whopping 201.35 times subscription, indicating huge interest from investors. Investors are now eagerly awaiting its allotment even its latest GMP shows a strong 22.92% listing gains. The allotment of the Influx Healthtech IPO is expected to be finalised today, Monday, June 23, in the evening. Once the IPO allotment is finalised, investors will start receiving bank debit messages, most probably in the evening. They can also check their allotment status on the websites of the NSE as well as registrar Maashitla Securities Private Limited. The allotment is expected to be finalised in the evening today, Friday, June 20. The allotment status can be checked by following these steps: Step 1: Visit Maashitla Securities' portal — Step 2: Under 'Select Company', choose 'Influx Healthtech Ltd'. Importantly, if the company's name is not visible in the drop-down list, it means the allotment has not been finalised yet. According to market observers, the GMP of the Influx Healthtech IPO is 22.92%, indicating decent listing gains for investors. The GMP is based on market sentiments and keeps changing. 'Grey market premium' indicates investors' readiness to pay more than the issue price. Influx Healthtech IPO Listing Date The shares of Influx Healthtech Ltd will be listed on the NSE Emerge on June 25. The Influx Healthtech IPO was open for subscription between June 18 and June 20. It is a book-built issue worth Rs 58.57 crore, comprising a fresh issue of 50 lakh equity shares worth Rs 48 crore and an offer for sale of 11 lakh shares aggregating to Rs 10.56 crore. On the final day of bidding on Friday, the SME IPO received an overwhelming 201.35 times subscription, garnering bids for 81,71,71,200 shares as against 40,58,400 shares on offer. The retail and NII participation stood at 117.68 times and 481.10 times, respectively. Its qualified institutional buyer (QIB) category got a 137.87 times subscription. The price of the Influx Healthtech IPO was fixed at Rs 96 apiece. Influx Healthtech Ltd's revenue increased 5% and its profit after tax (PAT) rose 19% between the financial year ending with March 31, 2025, and March 31, 2024. Rarever Financial Advisors Pvt Ltd is the book-running lead manager of the Influx Healthtech IPO, while Maashitla Securities Private Limited is the registrar for the issue. The market maker for Influx Healthtech IPO is R K Stock Holding Private Limited. Influx Healthtech Ltd, founded in September 2020, is a healthcare-focused CDMO with three manufacturing units in Thane, producing tablets, capsules, powders, liquid orals, and softgels.

Time of India

18 minutes ago

• Time of India

Orders soar for Taiwan cleanroom firms amid global chip industry expansion

Much of this growth is tied to TSMC's massive investment of $65 billion in three chip factories, known as "fabs," in Arizona. The first fab has already started mass production, and the second is nearly finished. With a total order backlog of NTD (New Taiwan dollar) 132.27 billion ($4.45 billion), UIS is expected to receive even more orders later in 2025. Experts predict the company will have its highest-ever sales in 2025. Tired of too many ads? Remove Ads Tired of too many ads? Remove Ads Taiwanese cleanroom companies are receiving a wave of new orders as major global chipmakers expand production around the world, especially in the United States and Southeast Integrated Services Co. (UIS), a longtime supplier to Taiwan Semiconductor Manufacturing Co. (TSMC), is one of the main winners in this January to May 2025, UIS secured NTD (New Taiwan dollar) 83.68 billion ($2.57 billion) in cleanroom-related contracts -- a new record for the of this growth is tied to TSMC's massive investment of $65 billion in three chip factories, known as "fabs," in Arizona. The first fab has already started mass production, and the second is nearly a total order backlog of NTD 132.27 billion ($4.45 billion), UIS is expected to receive even more orders later in 2025. Experts predict the company will have its highest-ever sales in 2025.L&K Engineering Co., another major cleanroom provider, is also seeing strong demand. It reported NTD 95.76 billion (USD 3.23 billion) in new orders in the first five months of the year, largely from Taiwanese firms building new fabs in Southeast Asia.L&K now has a total backlog of NTD 208.49 billion ($7.02 billion). Some of this comes from projects with United Microelectronics Corp. (UMC), which recently opened a new fab in there will start in 2026. L&K is also working with Vanguard International Semiconductor Corp., which is building a 12-inch fab in Singapore with Dutch company NXP Semiconductors. That plant will start production in Taiwanese firms like Acter Group Corp. and Yankey Engineering Co. are also doing well. Acter now holds over NTD 46 billion ($1.55 billion) in orders, up from NTD 38 billion ($1.28 billion) at the end of 2024, helped by business from chip packaging company Siliconware Precision Industries Engineering has NTD 40.67 billion ($1.37 billion) in orders, supported in part by Dutch equipment maker ASML's expansion in are a critical part of chipmaking. They remove dust and other particles that could damage delicate components during production. As chip companies grow worldwide, demand for these high-tech spaces is rising -- and Taiwanese firms are leading the way.

India.com

19 minutes ago

• India.com

Good news for Anil Ambani, another company settles Rs 2730000000 loan of…, with…

Anil Ambani was already in the news for settling down the debt of his many companies. Now once again it has settled the debt with another company. In a recent exchange filing it stated that it has fully settled a Rs 273-crore loan, including interest, owed by its wholly owned subsidiary JR Toll Road Pvt Ltd (JRTR) to Yes Bank Ltd. It stated, '' A wholly owned subsidiary of the Company (along with the Company as Corporate Guarantor), has entered into an addendum to the Settlement Agreement today with Yes Bank Limited (YBL) for the entire outstanding debt obligation of ~INR 273 crore (including interest) owed by JRTR to YBL, and has duly paid the entire settlement amount.'' Anil Ambani Company Debt Reduction Debt reduction has become a primary focus for Anil Ambani. Reliance Infrastructure: Paid off Rs 3,300 crore of debt in FY 2025, becoming debt-free. Rosa Power Supply Company: Cleared Rs 485 crore of debt, achieving debt-free status. Reliance Power: Settled a loan of Rs 3,872 crore earlier. JR Toll Road Pvt Ltd, a special purpose vehicle established by Reliance Infrastructure, is responsible for the development, operation, and maintenance of a 52-kilometer segment of National Highway 11, connecting Jaipur and Reengus in Rajasthan. The project was executed under the Design-Build-Finance-Operate-Transfer (DBFOT) model, featuring a highway expansion from four to six lanes. Operations commenced in 2013, coinciding with the start of toll collection.